～Speaker～
Dr. Amy Hsiao
Manager, Acer Healthcare
Speaker's Biography
Dr. Hsiao has over 15 years of experience in the field of biomedical engineering. She received her doctoral degree in Biomedical Engineering from the University of Michigan and a post-doctoral fellowship at The University of Tokyo. During her tenure in academia, her research focused on applying micro-technologies to tissue engineering and regenerative medicine. She subsequently went into the biotech industry and has since worked in various functions, including research and development, project management, and business development. She joined Acer Healthcare's business development team in 2020 and has recently transitioned to take on a new role in the product strategy and management team.
Topic
Transforming diabetic
retinopathy screening through an AI-based solution - VeriSee DR
Abstract
With
the growing number of people with diabetes worldwide, the traditional practice
of manual screening of diabetic retinopathy (DR) by diabetes and eye care
specialists cannot scale up. While annual DR screening is recommended for all
diabetic patients, only less than 50% of patients get screened even in the
developed world. To address this challenge, Acer Healthcare developed VeriSee
DR, an artificial intelligence (AI) assisted diagnostic software for DR.
VeriSee DR uses AI to analyze images of the retina for signs of DR and assists
healthcare professionals to interpret the images. After the patient's retinal
images are taken, the images will be analyzed by AI, and a binary result
(non-referable vs. referable) will be output within a few seconds. The patient
will receive immediate feedback on whether he/she should be referred to an
ophthalmologist or come back for normal annual testing. VeriSee DR's accuracy
of 93% is comparable to ophthalmologists, and it is expected to bring real
impacts to remote areas where medical resources are scarce. It is an effective
solution that can shorten the screening process, increase the volume of
screenings, improve the accuracy and consistency of the results, reduce costs,
and improve patient outcomes.
Slide and Additional Information
Link: https://reurl.cc/YOol0l
